University College London Hospitals v KG [2018] EWCOP 29

University College London Hospitals NHS Foundation Trust was seeking the court's authority to administer a treatment known as PRN100 to a patient who was suffering from sporadic CJD. Permission was granted.

The P was suffering from ​​sporadic CJD (a life threatening condition where the P may survive only 6 months) and he and his family wanted to him to undergo  treatment with PRN100, a novel and experimental treatment. The court had to weigh up the risks and benefits of such treatment.

The court agreed that the P could undergo the treatment as it was plainly in his best interests.

Read the full text of the judgment on Bailii
​